Organization
Instituto Nacional de Cancerologia de Mexico
13 clinical trials
Clinical trial
A Phase I/II Open-label Clinical Trial to Evaluate the Pharmacokinetics of Alectinib With Sequential Dose Escalation in Patients Diagnosed With ALK-rearranged Advanced Non-small Cell Lung Cancer.Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Treatment of Serious and Critical Patients With COVID-19 With TocilizumabStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
A Phase III Study Comparing Concurrent Nitroglycerin With Radiation Therapy vs Radiation Therapy Alone in Patients With Non-small Cell Lung Cancer With EGFR Mutations and Brain Metastases.Status: Recruiting, Estimated PCD: 2025-02-23
Clinical trial
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Non-small Cell Lung Cancer PatientsStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer in Advanced Stage, Which Have Progressed to Chemotherapy. Analysis of Mutations in EGFR and Number of Copies of HER-2Status: Completed, Estimated PCD: 2014-06-01
Clinical trial
Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone for Patients With Advanced Non-small Cell Lung Cancer and EGFR Mutations: Phase 3 Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2024-07-14
Clinical trial
Ketamine Versus Placebo as Adjuvant Treatment for Major Depressive Disorder and Wish to Hasten Death in Advanced Cancer Patients Undergoing Palliative CareStatus: Completed, Estimated PCD: 2023-06-01
Clinical trial
Phase II, Open Label, Single Arm Trial of Alectinib in Combination With Bevacizumab in Untreated and Previously Treated Patients With Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) With Positive ALK Driver MutationStatus: Completed, Estimated PCD: 2022-08-01
Clinical trial
Effect of Glutamine Plus Lactobacillus Reuteri Added to an Astringent Diet in Preventing Diarrhea Caused by Tyrosine Kinase Inhibitors (TKIs) in Patients With Advanced Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992Status: Completed, Estimated PCD: 2014-07-01
Clinical trial
Phase II Randomized, Double Blind, Placebo Controlled Study of Whole-brain Irradiation With Concomitant Daily-dose Chloroquine for Brain Metastases.Status: Terminated, Estimated PCD: 2012-04-01
Clinical trial
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia Due to Enterobacteriaceae and Pseudomonas Aeruginosa in Hemato-oncological Patients With Severe Neutropenia and Fever: Non-inferiority StudyStatus: Recruiting, Estimated PCD: 2025-07-31